Flem.Merc. (FMN) Share Price

$SHPH Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
https://www.globenewswire.com/news-release/2024/11/26/2987539/0/en/Shuttle-Pharma-Expands-Patient-Enrollment-fo

FKA bioaQ You're not a shareholder Pinnochio, the company is deceased - the court said so - FACT.
The shares, just like the former company, are dead forever. You're too clueless to that fact.
You shouldn't be investing, someone that has a clue should be doing it for you.
As a m

Yes you are blessed indeed.very lucky man indeed.

*****🚽GME🚽 ( Gameturd ) Power2da lack of interest here

https://investorshub.advfn.com/Gamestop-Corporation-GME-4617

ENOUGH SAID HUZZAH🤪 !!!

Nice to see that my company’s HSA finally made a self-directed brokerage available. Goodbye Target 2035 Fund. Hello Anavex Life Sciences shares!

Ok stop eating!! Let’s go! lol 😂

$ILLR Triller is entering a new era under CEO Sean Kim, a visionary leader who’s reshaped digital platforms like TikTok and Amazon. His expertise signals a massive leap forward for Triller’s role in the creator economy, setting the stage for unprecedented growth. Investors, take note! 🚀 #ILL

Sell at $1.35 resistance unless it plans on going after )2.01

$ILLR Triller is entering a new era under CEO Sean Kim, a visionary leader who’s reshaped digital platforms like TikTok and Amazon. His expertise signals a massive leap forward for Triller’s role in the creator economy, setting the stage for unprecedented growth. Investors, take note! 🚀 #ILL

$CLCS - Cell Source, a biotechnology company, focused on developing cell therapy treatments based on the management of immune tolerance. The compamy’s patented Veto Cell technology is the centerpiece of treatment protocols that represent major breakthroughs in immune system management – safe and sel

I agree, KRTL is a rare animal in the otc, a lucrative industry and a micro float of 37 million shares. For example if the company can make $10 million a yr in net income divided by OS of 88 million that puts the PPS at .11 with no multiples or forward looking statements. Also $10 million is tiny

Netlist CEO opens up about $118 million jury verdict against Samsung
Nisha Shetty
28 November 2024





Netlist Inc CEO CK “Chuck” Hong says he feels vindicated after a Texas jury recently ordered Samsung Electronics Co to pay $118 million to

wasn't this supposed to $5 last thanksgiving?

who said no more updates, just PR?

hahahah #MRFOS

Go drones $1 level  hit sell lock in profits 

It doesn't matter if I respond to him. You guys are connected by the bellybutton and are working together to a*buse Bioamber's shareholders, i know this is a cross boarder foreign issuer and in Canada they don't have to disclose anything including the reorganization that's taking place and that's w

will terrible mgmr provide update finally?

JFBR: Moved up since R/S with profit taking on Fri., News this AM. Compliant this week.

FSR today?

https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1478505/abstract

https://www.jseaortho.org/index.php/jsao/article/view/223

I am interested in more than a put down. I would enjoy your expertise in espousing why my position is wrong. Anyone can say someone is wrong and that opinion is about as valuable as one share of LVVV. You should enlighten us on how my opinion and the opinion of every respected economist is errant.

Ready for $3's in December

https://www.newsfilecorp.com/release/231880/DevvStream-Enters-REC-Market-in-Asia-with-Medellin-Solar-Power-Facility-Partnership

BMRA...................https://stockcharts.com/h-sc/ui?s=BMRA&p=W&b=5&g=0&id=p86431144783